Hepatitis

Comparing and Contrasting Hepatitis Viruses

a. Modes of Transmission

●

HAV and HEV: Transmitted through the fecal-oral route, often due to contaminated food or water or close contact with infected individuals.123 Specifically, HEV-1 and HEV-2 are primarily spread via feces-contaminated water, while HEV-3 and HEV-4 are mainly transmitted through consuming infected pork.3

●

HBV, HCV, and HDV: Transmitted through parenteral routes, which means exposure to infected blood. This can occur through sexual contact, intravenous drug use, occupational needlestick injuries, or during childbirth.145

b. Signs and Symptoms

●

Acute stage: Most hepatitis viruses cause general flu-like symptoms and mild to moderate pain in the upper right abdomen.1 However, the severity of symptoms can vary depending on the specific virus and the age of the infected person. For instance, HBV symptoms become more severe with increasing age.4 Only about 20% of people with acute HCV infection experience symptoms.6

●

Progression: As the disease progresses, symptoms may include hepatomegaly (enlarged liver), jaundice (yellowing of the skin and eyes), and dark urine.1

c. Association with Chronic Hepatitis and/or Liver Cancer

●

Chronic Infection:

○

HBV: Can lead to chronic infection, especially in infants (90% of cases), increasing the risk of liver cirrhosis and hepatocellular carcinoma.4 Chronic HBV infection develops in 90% of infants, 30-60% of children under 4, and 5-10% of adults.7 25% of individuals with chronic HBV infection become chronic carriers.7

○

HCV: Frequently progresses to chronic liver disease, with 85% of infected individuals developing chronic infection.56 Approximately 20% of those with chronic HCV infection will develop cirrhosis over 20-25 years, significantly increasing their risk of hepatocellular carcinoma.6 HCV is responsible for a third of liver transplants in the U.S.6

○

HDV: Superinfection of chronic HBV carriers with HDV can cause chronic liver disease, accelerating the progression to cirrhosis and liver failure.8

●

Liver Cancer: Chronic HBV and HCV infections are major risk factors for hepatocellular carcinoma.46

d. Structure and Family

●

HAV and HEV: These are RNA viruses.23 HEV has four genotypes.3

●

HBV: A DNA virus.4

●

HCV: An RNA virus with seven genotypes.5

●

HDV: An RNA virus that requires the presence of HBV for replication.8

e. Treatment and Prevention

●

HAV:

○

Treatment: No specific treatment exists, but rest and fluids are recommended.2

○

Prevention: A formalin-inactivated HAV vaccine is available.2 HAV immune globulin is recommended for unvaccinated individuals who have been exposed to the virus.2

●

HBV:

○

Treatment: Chronic HBV infection is treated with antivirals, including alpha interferon and reverse transcriptase inhibitors.8

○

Prevention: Vaccination with the recombinant HBsAg vaccine is effective in preventing infection.8 Hepatitis B immune globulin (HBIG) is recommended for unvaccinated individuals exposed to HBV.48

●

HCV:

○

Treatment: The standard treatment for HCV is combination therapy with interferon and ribavirin.9

○

Prevention: Currently, no vaccine is available for HCV due to the virus's high mutation rates, which allows it to evade the immune system.9 There is no effective short-term prevention like HBIG or immune globulin for HCV.9

●

HDV: Prevention of HBV infection also prevents HDV infection, as HDV requires HBV for replication.8

●

HEV: No specific treatment or vaccine is mentioned in the sources.3

HAV Serologic Markers and Staging

IgM anti-HAV is the primary serologic marker for acute HAV infection.2

●

It appears during the initial stages of infection, peaks within the first few months, and then declines to undetectable levels within 6-12 months.10

●

Total anti-HAV antibodies (predominantly IgG) appear after IgM anti-HAV and indicate immunity to HAV, either from natural infection or vaccination.10 There is no specific test for HAV-IgG; however, if the total anti-HAV test is positive and the IgM anti-HAV test is negative, it indicates the presence of HAV-IgG.10

Methods for Detecting HAV Serologic Markers

ELISA (Enzyme-linked immunosorbent assay) is the primary method for detecting HAV serologic markers, including:10

●

HAV-IgM: Specifically detects IgM antibodies, indicating an acute infection.10

●

Total anti-HAV Ab: Detects both IgM and IgG antibodies, providing information about current or past infection and immunity.10

Table of HBV Serologic Markers

The "Core Window" Concept

The "core window" refers to a period during acute HBV infection when HBsAg may become undetectable, while anti-HBs has not yet appeared.11 This period can last for several weeks to months. During this time, the only detectable marker of infection may be IgM anti-HBc, which is crucial for diagnosing acute HBV infection during the core window.11

Two Carrier Profiles for HBV Infections

The sources describe two carrier profiles for HBV infections based on the presence or absence of HBeAg:12

1.

HBeAg-positive carriers: These individuals are highly infectious and have active viral replication. 5-10% of these carriers will eventually become anti-HBe positive carriers.12

2.

Anti-HBe-positive carriers: These carriers have lower infectivity compared to HBeAg-positive carriers.12

All individuals infected with HBV, regardless of carrier profile, are excluded from blood donation.12

Molecular Methods for Detecting Hepatitis Infections

Molecular methods primarily focus on detecting viral DNA or RNA in serum or plasma.1314 These methods are highly sensitive and specific and have various applications:

●

HBV DNA detection: Used to evaluate the effectiveness of antiviral therapy and diagnose atypical HBV infections.13 Real-time PCR can detect HBV DNA up to 21 days before HBsAg becomes detectable.13

●

HCV RNA detection: Used to confirm positive ELISA results, enable earlier diagnosis, detect infection in infants born to HCV-positive mothers, identify exposure in immunosuppressed individuals who might not mount a sufficient antibody response, and monitor viral load during treatment.14

Commonly used molecular methods include:

●

Target amplification: Techniques like PCR amplify specific regions of the viral genome.13

●

Branched DNA signal amplification and hybridization: A method that amplifies the signal from a target sequence without amplifying the target itself.13

●

Real-time PCR: A highly sensitive and specific method that allows for the quantification of viral load.13

Markers for Detecting Hepatitis in Blood Donations

All infected individuals are excluded from blood donation to prevent transmission.12 While the sources do not specify a list of all markers used, it can be inferred that tests for HBsAg and anti-HCV are used for detecting HBV and HCV infections, respectively, in blood donations.612

Coinfection and Superinfection

●

Coinfection: Occurs when an individual is simultaneously infected with two or more hepatitis viruses. For example, a person can be coinfected with HBV and HDV. In the case of HDV, this usually results in acute, self-limited hepatitis and is characterized by the presence of anti-HDV and IgM anti-HBc.8

●

Superinfection: Occurs when an individual with a chronic hepatitis infection, like chronic HBV, becomes infected with a second hepatitis virus. For example, a person with chronic HBV infection can become superinfected with HDV. In this scenario, superinfection often leads to chronic liver disease with a faster progression to cirrhosis and liver failure. Serologically, this is marked by the presence of anti-HDV and IgG anti-HBc.8

HCV Screening and Confirmation Assays

●

Screening: ELISA is the primary screening assay for HCV infection.6 It detects antibodies against structural and nonstructural proteins of the virus.6 However, false positives can occur.14

●

Confirmation: Recombinant Immunoblot Assays (RIBAs) are used to confirm positive ELISA results and improve the specificity of HCV diagnosis.14 Molecular assays that detect HCV RNA in the patient's serum or plasma, such as RT-PCR and branched DNA amplification, can also be used to confirm ELISA-positive results.14

HEV Serologic Markers and Infection Staging

●

IgM anti-HEV: This marker indicates an acute HEV infection.3

●

IgG anti-HEV: This marker suggests past exposure to HEV.3

Additionally, HEV RNA can be detected in blood or stool samples during the acute phase of infection.3

Basic Laboratory Tests Elevated in Liver Disease

The initial laboratory findings in liver disease often include elevated levels of:1

●

Bilirubin: A yellow pigment produced during the breakdown of red blood cells. Elevated bilirubin levels can indicate liver dysfunction and lead to jaundice.

●

ALT (Alanine aminotransferase): An enzyme primarily found in the liver. Elevated ALT levels suggest liver cell damage.

●

AST (Aspartate aminotransferase): Another enzyme found in the liver and other organs. Like ALT, elevated AST levels can indicate liver damage.